|Articles|February 22, 2001
VITEX Appoints New Member to Board of Directors
Advertisement
WATERTOWN, Mass--VI Technologies (VITEX) has announced the appointment of Joseph M. Limber to its Board of Directors.
Limber, currently the president and CEO of ACLARA BioSciences, Inc., has 25 years of biotechnology and pharmaceutical management experience.
VITEX is a biotechnology company responsible for developing products that inactive and remove pathogens in blood. Using nucleic acid chemistry, the company produced Inactine Pathogen Inactivation. The technology inactivates blood-borne viruses and bacteria and is in Phase II of clinical trials.
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Infection Control Today
1
AORN26: OR–SPD Collaboration Reduces Instrument Contamination and Improves Surgical Efficiency
2
AORN26: Teach-Back Method in PACU Discharge Education Reduces Surgical Site Infections
3
AORN26: Multidisciplinary Culture Change Cuts Colon SSI Rates by Over 27%
4
AORN26: Turning Infection Prevention Guidelines Into Practical Policies With a Scalable Framework
5